Discontinued — last reported Q1 '26
Business Segments · R&D
Animal Health — R&D
Merck & Co. Animal Health — R&D decreased by 10.4% to $112.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $95.00M to $112.00M. Over 3 years (FY 2022 to FY 2025), Animal Health — R&D shows an upward trend with a 10.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toR&D
How to read this metric
Higher investment generally signals a commitment to long-term growth and competitive advantage through innovation.
Detailed definition
Expenditures dedicated to the discovery, development, and clinical testing of new animal health products and technologie...
Peer comparison
Standard R&D metric for pharmaceutical and biotech companies.
Metric ID:
mrk_segment_animal_health_research_and_developmentHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.25M | $82.25M | $82.25M | $82.25M | $88.25M | $88.25M | $88.25M | $88.25M | $90.00M | $91.00M | $95.00M | $109.00M | $95.00M | $110.00M | $118.00M | $125.00M | $112.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.3% | +0.0% | +0.0% | +0.0% | +2.0% | +1.1% | +4.4% | +14.7% | -12.8% | +15.8% | +7.3% | +5.9% | -10.4% |
| YoY Change | — | — | — | — | +7.3% | +7.3% | +7.3% | +7.3% | +2.0% | +3.1% | +7.6% | +23.5% | +5.6% | +20.9% | +24.2% | +14.7% | +17.9% |
Range$82.25M – $125.00M
CAGR+8.0%
Avg YoY Growth+11.4%
Median YoY Growth+7.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s animal health — r&d?
- Merck & Co. (MRK) reported animal health — r&d of $112.00M in Q1 2026.
- How has Merck & Co.'s animal health — r&d changed year-over-year?
- Merck & Co.'s animal health — r&d increased by 17.9% year-over-year, from $95.00M to $112.00M.
- What is the long-term trend for Merck & Co.'s animal health — r&d?
- Over 3 years (2022 to 2025), Merck & Co.'s animal health — r&d has grown at a 10.8% compound annual growth rate (CAGR), from $329.00M to $448.00M.
- What does animal health — r&d mean?
- The amount spent on developing new animal health products and technologies.